See you at ASCB 2019

7 – 11 December 2019

Expedeon AG signs commercial agreement with Sona Nanotech

August 6th, 2019

The agreement will address limitations in the development of multiplex point-of-care Lateral Flow Assay diagnostic tests Halifax, Canada, Heidelberg, Germany and Cambridge, UK, 06 August 2019 Expedeon AG (Frankfurt: EXN; ISIN: DE000A1RFM03; Prime Standard) and Sona Nanotech Inc. (CSE: SONA) (“Sona”), today announced they have entered into a commercial agreement to address limitations in development…